Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States
PaperCitations, authors & open-access status
Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 47 citations, 2016 year and green oa status.
47
Citations
2016
Year
green
OA Status